Location: Home
  • search
  • go
  • Relate News
  • 10/10/2018New U.S. Rules on Foreign Investment to Curb Chinese Goldrush in U.S. ...
  • 10/10/2018SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...
  • 10/9/2018Chinese Prof at MD Anderson Cancer Center under Scrutiny for Spying
  • 10/9/2018Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...
  • 10/9/2018China's HIV/AIDS Cases Rise by 14%
  • 10/9/2018China: AstraZeneca’s New Engine for Growth and Innovation
  • 10/9/2018Beigene Teams up With Springworks to Target Advanced Solid Tumors
  • 10/9/2018Listed Chinese Pharma Cos Reports Positive Performance in H1
  • 10/9/2018NHC Reports Higher Health Literacy in China
  • 10/8/2018CDE Solicits Comments on Technical Requirements for Manufacturing Site...
  • 10/8/2018NMPA Issues Rules for Communications Related to Drug R&D and Techn...
  • 10/8/2018Innovent to Start US Trials of Anti-CD47 Cancer Drug
  • 10/8/2018Genscript Denies Fake Data Allegations after Shares Plunge
  • 10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...
  • 10/8/2018Yisheng Biopharma Cleared by NMPA to Proceed with PIKA Rabies Vaccine ...
  • 10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma
  • 10/8/2018Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs
  • 10/8/2018SCMP: Betting Big on Biotech
  • 10/8/2018CANbridge Submits NDA for NERLYNX (neratinib) in China
  • 9/30/2018How Does the Pharma Industry Fit into China's Grand Puzzle of Healthca...
  • 9/30/2018Financial-related Company News in Brief
  • 9/30/2018NMPA Issues Announcement Regarding Direct ADR Reporting by MAHs
  • 9/28/2018Recent Official and Executive Moves
  • 9/28/2018Novartis Enters Deal with CBMG to Make CAR-T Therapy Kymriah
  • 9/27/2018China’s Health Authorities Issue New Rules on Telemedicine
  • 9/27/2018I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics
  • 9/27/2018Alvotech and Changchun HiTech Agree to Codevelop Biosimilars in China
  • 9/27/2018VenatoRx and Everest Medicines Announce License Agreement for Cefepime...
  • 9/27/2018PharmaBlock Acquires Manufacturing Facility in China
  • 9/27/2018The Development of Antibody-drug Conjugates in China
  • Page:323/790 Total number of articles:23688: [First][<<] [321] [322] [323] [324] [325] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group